Medical Properties Trust

Medical Properties Trust

MPT· Finance· Fiscal year ends in December

CEO pay in FY2025

Edward K. Aldag, Jr. is the CEO of Medical Properties Trust and was paid $15.9M in FY2025 (Dec).

PayNo stock prices for these years
CEO pay is from each Medical Properties Trust proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1Edward K. Aldag, Jr.FY2025
  2. 2R. Steven HamnerFY2025
  3. 3Larry H. PortalFY2023
  4. 4J. Kevin HannaFY2025
  5. 5Charles R. LambertFY2024

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Medical Properties Trust paid its 3 named executives $25.8M in total in FY2025 (Dec). CEO Edward K. Aldag, Jr. was paid $15.9M of that.

Name
Edward K. Aldag, Jr.Chairman, President, and Chief Executive OfficerNot disclosedNot disclosed
R. Steven HamnerDirector, Executive Vice President and Chief Financial OfficerNot disclosedNot disclosed
J. Kevin HannaSenior Vice President, Controller and Chief Accounting OfficerNot disclosedNot disclosed
Larry H. PortalSenior Vice President, Senior Advisor to the CEONot disclosedNot disclosed
Charles R. LambertSenior Vice President of Finance and TreasurerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Medical Properties Trust. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board2

See all
  • Michael G. StewartLead independent director · 9 yr on the boardIndependentEnvironmental and Social Responsibility, Ethics, Nominating and Corporate Governance—Paid as an executive
  • C. Reynolds ThompsonDirector · 9 yr on the boardIndependentAudit, Compensation (Chair), Investment—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 13, 2026FY2025
Annual report10-KFeb 26, 2026FY2025
Proxy statementDEF 14AApr 17, 2025FY2024
Annual report10-KMar 3, 2025FY2024
Proxy statementDEF 14AApr 17, 2024FY2023
Annual report10-KFeb 29, 2024FY2023